Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25869657 | 0.95 | MAPT (0.36) | — | |
| SCHEMBL25869601 | 0.85 | ALDH1A1 (0.32) | ALDH1A1CES2CES1FFAR3HDAC3 | |
| SCHEMBL25869642 | 0.84 | TDP1 (0.30) | — | |
| SCHEMBL25869653 | 0.84 | MAPT (0.40) | ALDH1A1CES2CA1CA2 | |
| SCHEMBL25869618 | 0.84 | CA1 (0.36) | ALDH1A1CES2CA1CA2 | |
| SCHEMBL25869664 | 0.82 | GPR84 (0.31) | — | |
| SCHEMBL25869629 | 0.81 | CES2 (0.36) | CES2CES1CA1CA2 | |
| Ammonia Solution, Strong SCHEMBL28812113 | 0.81 | KMT2A (0.46) | ALDH1A1CES2CES1 | |
| SCHEMBL25869626 | 0.80 | MAPT (0.44) | CES2CES1CA1CA2 | |
| SCHEMBL25869616 | 0.80 | CA1 (0.40) | CES2CES1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11708324-B2 | Sulfuric acid ester or salt thereof, and surfactant | DAIKIN INDUSTRIES. LTD. (JP) | 2023-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11708324-B2 | Sulfuric acid ester or salt thereof, and surfactant | SRP54, NR4A1, NR4A3 | ALDH1A1 3345/4885CES2 3005/4885CES1 1901/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.